Castle Biosciences Secures $11,700,000 Series F Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94f0fb64-7245-43a5-b353-f0abd2c275bb
Date
7/27/2015
Company Name
Castle Biosciences
Mailing Address
2014 San Miguel Dr. Friendswood, TX 77546 USA
Company Description
Castle Biosciences develops and commercializes diagnostic and prognostic tests for cancers that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.
Website
http://www.castlebiosciences.com
Transaction Type
Venture Equity
Transaction Amount
$11,700,000
Transaction Round
Series F
Proceeds Purposes
The funding will be used to accelerate the growth in clinical adoption of the Company’s gene test for identifying metastatic risk in early stage cutaneous melanoma, DecisionDx-Melanoma, and its other tests designed to improve cancer care.
M&A Terms
Venture Investor
Industry Ventures
Venture Investor
HealthQuest Capital
Venture Investor
Mountain Group Capital